ํค๋ชจ๊ธ๋ก๋น ๊ธ๋ฃจํ๋จธ-200 (์ ์ ๋)
**ํค๋ชจ๊ธ๋ก๋น ๊ธ๋ฃจํ๋จธ-200 (์ ์ ๋)**๋ ์์ํ์์ ์ฃผ๋ก ์ฐ์ ์ด๋ฐ ์์ก ๋ฐ ๊ฐ๋ ฅํ ์ฝ๋ก์ด๋๋ก ์ฌ์ฉ๋๋ ๋ฐํฉ์ฑ ์คํฉ ์ ํค๋ชจ๊ธ๋ก๋น ์ ํ์ ๋๋ค. * **์ฃผ์ ์ ์์ฆ**: ์ ํ์ด๋ ๋์ถ ์ ํ๊ตฌ๋ฅผ ๊ตฌํ ์ ์๊ฑฐ๋ ๊ต์ฐจ์ํ์์ ์ ํฉํ ๊ณตํ๋๋ฌผ์ ์ฐพ์ง ๋ชปํ ๊ฒฝ์ฐ์ ๋นํ(์ฉํ, ์ถํ ๋๋ ๋ฌดํจ ์กฐํ๋ก ์ธํ) ์น๋ฃ. * **์์์ ์ง์ฃผ**: ์ฌ์์ฑ ๋นํ ๋ฐ ์๊ธ ์ธ์ ์ํฉ์์ ํนํ ์ ์ฉํฉ๋๋ค. ๊ธฐ์ง์ด ์๊ณ ์ ํ๊ตฌ ๋ง์ด ์๊ธฐ ๋๋ฌธ์ ํฌ์ฌ ์ ํ์กํ ๊ฒ์ฌ๋ ๊ต์ฐจ์ํ์ด ํ์ํ์ง ์์ต๋๋ค. * **ํ๊ฐ ์ธ ์ฌ์ฉ**: ๊ณ ์์ด ๋ฐ ์ ์์ ๋์ข ๋ฉด์ญ ์ฉํ์ฑ ๋นํ์ด ์๋ ๋ง์์ง์๊ฒ๋ ์ฌ์ฉ๋ ๋ฐ ์์ผ๋, ๊ฐ๋ ฅํ ์ฝ๋ก์ด๋ ํน์ฑ์ผ๋ก ์ธํด ๊ทน๋์ ์ฃผ์๊ฐ ํ์ํฉ๋๋ค.
์์ฉ ๊ธฐ์ : HG-200 functions both as an oxygen carrier and a potent colloid expander: * **Oxygen Delivery**: Releases oxygen to tissues similarly to endogenous hemoglobin. It **shifts the oxygen dissociation curve to the right**, facilitating easier oxygen offloading to hypoxic tissues. * **Microvascular Perfusion**: Due to its small molecular size compared to intact RBCs, it can bypass severe arterial constrictions to oxygenate ischemic cells. * **Colloidal Effect**: Acts as a potent colloid (similar to dextran 70 or hetastarch), expanding intravascular volume by increasing oncotic pressure. * **Vascular Tone**: Causes significant **vasoconstriction**, which can increase blood pressure but may decrease cardiac output in hypovolemic states.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- As an option to provide oxygen carrying capacity in the trauma patient ยท 2.5-10 mL/kg ยท IV ยท Given over several hours ยท Care must be taken not to cause fluid overload especially in cats.
- Labeled indications (anemia) ยท 10-30 mL/kg ยท IV ยท One-time dose at a rate of up to 10 mL/kg/hr ยท Do not administer with other fluids or drugs via the same infusion set.
- Resuscitation of trauma patients in shock with or without hemorrhage ยท 3-5 mL/kg ยท IV ยท Once ยท With concurrent crystalloid at 1/2 to 2 times maintenance.
- To provide a 'bridge' until immunosuppressive drugs take effect in dogs with IMHA with a transfusion reaction ยท 7-10 mL/kg or 30 mL/kg ยท IV ยท q12h (for 7-10 mL/kg dose) ยท 48-72 hours (for 30 mL/kg dose) ยท 7-10 mL/kg maintains Hb >3.5 g/dL; 30 mL/kg provides support for 48-72h.
- As an option to provide oxygen carrying capacity in the trauma patient ยท 10-15 mL/kg ยท IV ยท Given over several hours ยท Care must be taken not to cause fluid overload.
- As a vasopressor once there is adequate intravascular volume in trauma patients ยท 3-5 mL/kg ยท IV ยท Once
์ฉ๋์ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์ฐธ๊ณ ์๋ฃ์ ๋๋ค. ํญ์ ์ต์ ๋ผ๋ฒจ๊ณผ ๊ฐ๋ณ ํ์์ ๋ํด ํ์ธํ์ญ์์ค.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Advanced cardiac disease (e.g., congestive heart failure)
- Severely impaired cardiac function
- Renal impairment with oliguria or anuria
์ด์๋ฐ์
- Discolored mucous membranes, sclera, skin (yellow, red, brown)
- Discolored urine (orange, red, brown)
- Increased central venous pressure (CVP)
- Ventricular arrhythmias (AV block, tachycardia, VPCs)
- Vomiting, diarrhea, anorexia
- Tachypnea, dyspnea, harsh lung sounds
- Pulmonary edema and pleural effusion (due to volume overload)
- Fever
- Peripheral edema
- Hemoglobinuria
๋ชจ๋ํฐ๋ง
- Hemoglobin levels
- Clinical signs of adequate tissue oxygenation
- Central venous pressure (CVP) and signs of circulatory overload
- Respiratory rate and effort (watch for pulmonary edema)
- Heart rate and rhythm (watch for arrhythmias)
๊ณผ์ฉ๋
Clinical signs of overdosage (1 to 3 times the recommended dose) include yellow-orange discoloration of skin, mucous membranes, and sclera; red-dark-green-black feces; brown-black urine; decreased appetite/thirst; vomiting; diarrhea; and decreased skin elasticity. Overdosage or excessively rapid administration (>10 mL/kg/hr) may result in severe circulatory overload (pulmonary edema, pleural effusion).
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.